# Xiuxin Han

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xiuxin-han/

## Facts

| Field | Value |
| --- | --- |
| Citations | 791 |
| Field | Sarcoma Diagnosis and Treatment |
| h-index | 18 |
| i10-index | 20 |
| Last Known Institution | National Medical Products Administration |
| OpenAlex ID | https://openalex.org/A5101931376 |
| ORCID iD | 0000-0001-6745-8794 |
| Works | 37 |

## Researcher papers

- [Twenty‐year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors](https://scholariq.org/papers/twenty-year-outcome-of-prevalence-incidence-mortality-and-survival-rate-in/)
- [Role of Nectin‑4 protein in cancer (Review)](https://scholariq.org/papers/role-of-nectin-4-protein-in-cancer-review/)
- [Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study](https://scholariq.org/papers/lung-metastases-at-the-initial-diagnosis-of-high-grade-osteosarcoma-prevalence/)
- [Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer](https://scholariq.org/papers/nomogram-based-on-homogeneous-and-heterogeneous-associated-factors-for/)
- [The homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancer](https://scholariq.org/papers/the-homogeneous-and-heterogeneous-risk-factors-for-the-morbidity-and-prognosis/)
- [Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma](https://scholariq.org/papers/coexpression-of-cxcr4-and-mmp9-predicts-lung-metastasis-and-poor-prognosis-in/)
- [Real-World Study of the Incidence, Risk Factors, and Prognostic Factors Associated with Bone Metastases in Women with Uterine Cervical Cancer Using Surveillance, Epidemiology, and End Results (SEER) Data Analysis](https://scholariq.org/papers/real-world-study-of-the-incidence-risk-factors-and-prognostic-factors-associated/)
- [Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study](https://scholariq.org/papers/incidence-of-bone-metastasis-and-factors-contributing-to-its-development-and/)
- [PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway](https://scholariq.org/papers/pla2g16-promotes-osteosarcoma-metastasis-and-drug-resistance-via-the-mapk/)
- [Bone Metastases Pattern in Newly Diagnosed Metastatic Bladder Cancer: A Population-Based Study](https://scholariq.org/papers/bone-metastases-pattern-in-newly-diagnosed-metastatic-bladder-cancer-a/)

## Researcher topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Management of metastatic bone disease](https://scholariq.org/topics/management-of-metastatic-bone-disease/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)
- [Cancer Diagnosis and Treatment](https://scholariq.org/topics/cancer-diagnosis-and-treatment/)

## Researcher university

- [National Medical Products Administration](https://scholariq.org/institutions/national-medical-products-administration/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.